Taipei, Taiwan

Shih-Ku Lin

This inventor holds 1 USPTO granted patent. Top assignee: Medical and Pharmaceutical Industry Technology and Development Center. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shih-Ku Lin. Retrieved from https://idiyas.com/inventor/shih-ku-lin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shih-Ku Lin: Innovator in Pharmaceutical Composition

Introduction

Shih-Ku Lin is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of mental disorders. His innovative approach focuses on enhancing the efficacy of antipsychotic medications through modified release mechanisms.

Latest Patents

Shih-Ku Lin holds 1 patent for a modified release pharmaceutical composition and method for the treatment of mental disorders. This invention involves a composition that includes an effective amount of at least one antipsychotic agent. The unique aspect of this patent is the manner in which the antipsychotic agents are released, aligning better with the physiological and chronotherapeutic needs of patients.

Career Highlights

Lin is associated with the Medical and Pharmaceutical Industry Technology and Development Center, where he applies his expertise to advance pharmaceutical technologies. His work is pivotal in developing solutions that address complex mental health issues.

Collaborations

Some of his notable coworkers include Tse-Ching Lin and Lai-Cheng Chin, who contribute to the collaborative efforts in research and development within the center.

Conclusion

Shih-Ku Lin's innovative work in pharmaceutical compositions showcases his commitment to improving mental health treatments. His contributions are vital in the ongoing quest for effective therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…